LANITA REID: Open Payments
NPI 1508935271 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,171 in 51 payments from 14 companies in 2025. Trend: 2023 $779 · 2024 $875 · 2025 $1,171
Food & beverage: $1,171
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $392 |
| Vifor Pharma, Inc. | 6 | $150 |
| Calliditas Therapeutics US Inc. | 6 | $148 |
| Otsuka America Pharmaceutical, Inc. | 5 | $95 |
| OPKO Pharmaceuticals, LLC | 5 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $73 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Ardelyx, Inc. | 2 | $45 |
| Mallinckrodt Hospital Products Inc. | 1 | $29 |
| AKEBIA THERAPEUTICS INC | 1 | $28 |
Products named: Fabhalta, Veltassa, TARPEYO, JYNARQUE, RAYALDEE, JARDIANCE, FARXIGA, IBSRELA.
Industry payments across AL — which companies pay providers there.
